Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004285 · ClinicalTrials.gov registry record · NA
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- NA
- Development phase
- 1,846
- Enrollment target
NCT00004285 is a NA study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 1,846 participants.
The verdict
NCT00004285, a NA study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- NA
- Development phase
- 1,846 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Evaluate whether hemodialysis providing a 2-pool, variable volume urea kinetic modelling value of 1.05 versus 1.45 reduces mortality and morbidity in patients with end stage renal disease. II. Compare the efficacy of high versus low flux dialyzer membranes.
Interventions
- DEVICE Standard dose, low flux hemodialysis
- DEVICE Standard dose, high flux hemodialysis
- DEVICE High dose, low flux hemodialysis
- DEVICE High dose, high flux hemodialysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,846 participants |
| Start Date | 1995-03 |
| Est. Completion | 2001-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004285
The ClinicalTrials.gov registry entry for NCT00004285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,846 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Standard dose, low flux hemodialysis is the first listed.
NCT00004285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004285 about?
NCT00004285 is a clinical study titled "Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis". OBJECTIVES: I. Evaluate whether hemodialysis providing a 2-pool, variable volume urea kinetic modelling value of 1.05 versus 1.45 reduces mortality and morbidity in patients with end stage renal disease. II. Compare the efficacy of high versus low flux dialyzer membranes.
What is the current status of trial NCT00004285?
This trial is currently completed. It is a NA study. The enrollment target is 1,846 participants. The study started on 1995-03. Estimated completion is 2001-12-31.
What interventions are being tested in trial NCT00004285?
The interventions under investigation include: Standard dose, low flux hemodialysis (DEVICE), Standard dose, high flux hemodialysis (DEVICE), High dose, low flux hemodialysis (DEVICE), High dose, high flux hemodialysis (DEVICE).
Who is sponsoring clinical trial NCT00004285?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.